artemisinin-based combination therapies

R&D

The UK must sustain investment in malaria R&D as it faces a “perfect storm” of challenges, including mosquito resistance to existing tools.

News

Bayer chases after Boehringer with an FDA approval for oral HER2 inhibitor Hyrnuo in previously untreated HER2+ lung cancer.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.